Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Randomized, Comparative, Multi-centre Investigation Evaluating the Efficacy and Tolerance of Mepilex Ag Versus Silver Sulfadiazine in the Treatment of Deep Partial Thickness Burn Injuries.

NCT01439074 is registered in ClinicalTrials.gov with Molnlycke Health Care AB as lead sponsor.

NCT NCT01439074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01439074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Randomized, Comparative, Multi-centre Investigation Evaluating the Efficacy and Tolerance of Mepilex Ag Versus Silver Sulfadiazine in the Treatment of Deep Partial Thickness Burn Injuries.
Lead sponsor
Molnlycke Health Care AB
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
September 30, 2013
Enrollment
162 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

burn injuries